Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Depreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Skinvisible (SKVI) Shares Outstanding (2016 - 2025)

Skinvisible (SKVI) has disclosed Shares Outstanding for 16 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.64% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Dec 2025, up 1.64% year-over-year, with the annual reading at $5.4 million for FY2025, 1.64% up from the prior year.
  • Shares Outstanding hit $5.4 million in Q4 2025 for Skinvisible, roughly flat from $5.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $5.4 million in Q1 2025 to a low of $4.5 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $4.8 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding: changed 0.0% in 2021 and later increased 19.03% in 2025.
  • Year by year, Shares Outstanding stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then increased by 17.12% to $5.3 million in 2024, then grew by 1.64% to $5.4 million in 2025.
  • Business Quant data shows Shares Outstanding for SKVI at $5.4 million in Q4 2025, $5.4 million in Q3 2025, and $5.4 million in Q2 2025.